Patents Represented by Attorney Brian McCaslin

Find this attorney in the Justia Lawyer Directory

  • Therapeutic use for treating of leukemia
    Patent number: 8236811
    Abstract: The disclosure relates to methods of treating leukaemia, in particular myeloid leukaemia, comprising administering the compound N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N?-(1,1-dimethylethyl)-urea or a hydrate, a pharmaceutically acceptable salt or a solvate thereof.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: August 7, 2012
    Assignee: Sanofi
    Inventors: Bernard Bourrie, Pierre Casellas
  • Oxaliplatin active substance with a very low content of oxalic acid
    Patent number: 8211940
    Abstract: The present invention relates to an oxaliplatin active substance for a pharmaceutical composition, wherein its weight content in oxalic acid is not more than 0.08%, and to a process of preparing the active substance.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: July 3, 2012
    Assignee: Debiopharm S.A.
    Inventors: Houssam Ibrahim, Rolland-Yves Mauvernay
  • Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
    Patent number: 8008310
    Abstract: Derivatives of pyrido[2,3-d]pyrimidine are provided having formula (I) with Ar1, Ar2 and R1 as defined herein, which are useful for treating cell proliferative conditions, and to the preparation thereof, and to the therapeutic application of the same.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: August 30, 2011
    Assignee: Sanofi-Aventis
    Inventors: Bernard Bourrie, Pierre Casellas, Samir Jegham, Claude Muneaux, Pierre Perreaut